Reply letter to "Primary surgical treatment of pelvic aggressive angiomyxoma is not always advisable in ER positive patients"

H Bai¹, K Shen²

Affiliations

¹ Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China. Electronic address: shenkeng@sina.vip.com.
² Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.

Comment

H Bai et al. Eur J Surg Oncol. 2014 May.

. 2014 May;40(5):594-595.

doi: 10.1016/j.ejso.2014.02.230. Epub 2014 Feb 28.

H Bai¹, K Shen²

¹ Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China. Electronic address: shenkeng@sina.vip.com.
² Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.

No abstract available

Comment on

Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis.
Bai HM, Yang JX, Huang HF, Cao DY, Chen J, Yang N, Lang JH, Shen K. Bai HM, et al. Eur J Surg Oncol. 2013 Oct;39(10):1101-8. doi: 10.1016/j.ejso.2013.06.013. Epub 2013 Jul 27. Eur J Surg Oncol. 2013. PMID: 23899874
Primary surgical treatment of pelvic aggressive angiomyxoma is not always advisable in ER positive patients.
Sandrucci S, Comandone S, Boglione A. Sandrucci S, et al. Eur J Surg Oncol. 2014 May;40(5):592-593. doi: 10.1016/j.ejso.2013.12.027. Epub 2014 Feb 28. Eur J Surg Oncol. 2014. PMID: 24630771 No abstract available.